The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Kumar Neil

Reporting owner CIK 0001742485 · Chief Executive Officer · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Kumar NeilKumar NeilKumar Neil · December 12, 2025 · Exercise / conversion · Common StockKumar Neil · November 16, 2025 · Exercise / conversion · Common StockKumar Neil · November 16, 2025 · Exercise / conversion · Common StockKumar Neil · November 16, 2025 · Exercise / conversion · Common StockNov 16, 2025Dec 12, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

4 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 12, 2025BridgeBio Pharma, Inc.Common StockKumar NeilExercise / conversion
Nov 16, 2025BridgeBio Pharma, Inc.Common StockKumar NeilExercise / conversion
Nov 16, 2025BridgeBio Pharma, Inc.Common StockKumar NeilExercise / conversion
Nov 16, 2025BridgeBio Pharma, Inc.Common StockKumar NeilExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: BridgeBio Pharma, Inc.BBIO · company listings
Kumar NeilChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M60,975Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: BridgeBio Pharma, Inc.BBIO · company listings
Kumar NeilChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M11,554Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: BridgeBio Pharma, Inc.BBIO · company listings
Kumar NeilChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M19,599Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: BridgeBio Pharma, Inc.BBIO · company listings
Kumar NeilChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M33,544Not reported *Value: Not reportedCurrency not specifiedView ↗